The global study on the liquid dosage excipients assesses growth opportunities in the oral liquid and parenteral excipients market from 2022 to 2030 across major regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The oral liquid excipients market provides qualitative and quantitative analyses of different segments such as sweetening agents, pH modifiers and buffering agents, wetting/solubilizing agents, and others (e.g., chelating agents, preservatives, and flavors). The increase in new drug approvals in the oral liquid formulation space to treat various diseases in children and older adults will drive demand over the forecast period. The segments examined under the global parenteral excipients market include solubilizing agents, buffering agents, preservatives, and others (e.g., tonicity adjusters, chelating agents, antioxidants, and bulking agents). Demand for biologics drugs to treat diseases such as cancer, orphan diseases, and cardiovascular diseases will be the primary growth contributor in the parenteral excipients market during the forecast period.
Author: Akheela Dhiman
Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Liquid Dosage Excipient Industry
Growth Opportunities Fuel the Growth Pipeline Engine™
Scope of Analysis
Segmentation
Segmentation (continued)
Market Definitions—Pharmaceutical Excipients
Market Definitions
Market Definitions (continued)
Market Definitions—Other Key Definitions
Key Competitors
Global Pharmaceutical Market Overview
Global Pharmaceutical Market Trends
Growth Drivers
Growth Drivers Analysis
Growth Drivers Analysis (continued)
Growth Driver Analysis (continued)
Growth Drivers Analysis (continued)
Growth Drivers Analysis (continued)
Growth Restraints
Growth Restraint Analysis
Growth Restraint Analysis (continued)
Value Chain
Growth Metrics
Forecast Assumptions
Forecast Assumptions (continued)
Revenue Forecast
Revenue Forecast Analysis
Revenue Forecast by Type
Revenue Forecast by Region
Forecast Analysis by Type and Region
Competitive Environment
Competitive Ecosystem
Competitive Benchmarking
Competitive Benchmarking (continued)
Competitive Benchmarking (continued)
Market Activities—New Product Launches, M&As, Partnerships, and Expansions, 2020–2023
Market Activities—New Product Launches, M&As, Partnerships, and Expansions, 2020–2023 (continued)
Pricing Trends and Forecast Analysis
Growth Metrics
Revenue Forecast
Revenue Forecast by Type
Revenue Forecast by Region
Forecast Analysis
Forecast Analysis by Type
Forecast Analysis by Type (continued)
Forecast Analysis by Region
Forecast Analysis by Region (continued)
Growth Metrics
Revenue Forecast
Revenue Forecast by Type
Revenue Forecast by Region
Forecast Analysis
Forecast Analysis by Type
Forecast Analysis by Type (continued)
Forecast Analysis by Region
Forecast Analysis by Region (continued)
Growth Opportunity 1—Need for an Independent Approval Pathway for Novel Excipient Development
Growth Opportunity 1—Need for an Independent Approval Pathway for Novel Excipient Development (continued)
Growth Opportunity 2—mRNA-based Therapeutics
Growth Opportunity 2—mRNA-based Therapeutics (continued)
Growth Opportunity 3—Need for Effective Pediatric Drug Delivery Solutions
Growth Opportunity 3—Need for Effective Pediatric Drug Delivery Solutions (continued)
Growth Opportunity 4—Differentiated Capabilities for Injectable Specialty Generics
Growth Opportunity 4—Differentiated Capabilities for Injectable Specialty Generics (continued)
Your Next Steps
Why Frost, Why Now?
List of Exhibits
List of Exhibits (continued)
Legal Disclaimer
List of Figures- Liquid Dosage Excipients: Definition by Type, Oral Liquid, Global, 2022
- Liquid Dosage Excipients: Definition by Type, Parenteral, Global, 2022
- Other Key Definitions, Global, 2022
- Small Molecule: Revenue Forecast, Global, 2020–2027
- Biologics: Revenue Forecast, Global, 2020–2027
- Liquid Dosage Excipients: Growth Drivers, Global, 2023–2030
- Pharmaceuticals: Therapeutic Segment Market Share (%), Global
- Total Pharmaceutical R&D Spending, Global, 2020–2027
- Liquid Dosage Excipients: Growth Restraints, Global, 2023–2030
- Liquid Dosage Excipients: Value Chain Analysis, Global, 2022
- Liquid Dosage Excipients: Growth Metrics, Global, 2022
- Liquid Dosage Excipients: Revenue Forecast, Global, 2020–2030
- Liquid Dosage Excipients: Revenue Forecast by Type, Global, 2020–2030
- Liquid Dosage Excipients: Revenue Forecast by Region, Global, 2020–2030
- Liquid Dosage Excipients: Competitive Environment, Global, 2022
- Liquid Dosage Excipients: Competitive Landscape, Global, 2022
- Liquid Dosage Excipients: Competitive Benchmarking, Global, 2022
- Oral Liquid Excipients: Growth Metrics, Global, 2022
- Oral Liquid Excipients: Revenue Forecast, Global, 2020–2030
- Oral Liquid Dosage Excipients: Revenue Forecast by Type, Global, 2020–2030
- Oral Liquid Dosage Excipients: Revenue Forecast by Region, Global, 2020–2030
- Latest Oral Liquid Drugs FDA Approvals for Children, United States, 2023
- Parenteral Excipients: Growth Metrics, Global, 2022
- Parenteral Excipients: Revenue Forecast, Global, 2020‒2030
- Parenteral Excipients: Revenue Forecast by Type, Global, 2020‒2030
- Parenteral Excipients: Revenue Forecast by Region, Global, 2020‒2030
- Latest Parenteral Drug FDA Approvals for 2023, United States
Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
The global study on the liquid dosage excipients assesses growth opportunities in the oral liquid and parenteral excipients market from 2022 to 2030 across major regional markets, including North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. The oral liquid excipients market provides qualitative and quantitative analyses of different segments such as sweetening agents, pH modifiers and buffering agents, wetting/solubilizing agents, and others (e.g., chelating agents, preservatives, and flavors). The increase in new drug approvals in the oral liquid formulation space to treat various diseases in children and older adults will drive demand over the forecast period. The segments examined under the global parenteral excipients market include solubilizing agents, buffering agents, preservatives, and others (e.g., tonicity adjusters, chelating agents, antioxidants, and bulking agents). Demand for biologics drugs to treat diseases such as cancer, orphan diseases, and cardiovascular diseases will be the primary growth contributor in the parenteral excipients market during the forecast period.
Author: Akheela Dhiman
| Deliverable Type | Market Research |
|---|---|
| Author | Akhila Dhiman |
| Industries | Chemicals and Materials |
| No Index | No |
| Is Prebook | No |
| Keyword 1 | Excipient Industry Growth |
| Keyword 2 | Liquid Pharmaceutical Additives |
| Keyword 3 | Pharmaceutical Excipient Market |
| List of Charts and Figures | Liquid Dosage Excipients: Definition by Type, Oral Liquid, Global, 2022~ Liquid Dosage Excipients: Definition by Type, Parenteral, Global, 2022~ Other Key Definitions, Global, 2022~ Small Molecule: Revenue Forecast, Global, 2020–2027~ Biologics: Revenue Forecast, Global, 2020–2027~ Liquid Dosage Excipients: Growth Drivers, Global, 2023–2030~ Pharmaceuticals: Therapeutic Segment Market Share (%), Global~ Total Pharmaceutical R&D Spending, Global, 2020–2027~ Liquid Dosage Excipients: Growth Restraints, Global, 2023–2030~ Liquid Dosage Excipients: Value Chain Analysis, Global, 2022~ Liquid Dosage Excipients: Growth Metrics, Global, 2022~ Liquid Dosage Excipients: Revenue Forecast, Global, 2020–2030~ Liquid Dosage Excipients: Revenue Forecast by Type, Global, 2020–2030~ Liquid Dosage Excipients: Revenue Forecast by Region, Global, 2020–2030~ Liquid Dosage Excipients: Competitive Environment, Global, 2022~ Liquid Dosage Excipients: Competitive Landscape, Global, 2022~ Liquid Dosage Excipients: Competitive Benchmarking, Global, 2022~ Oral Liquid Excipients: Growth Metrics, Global, 2022~ Oral Liquid Excipients: Revenue Forecast, Global, 2020–2030~ Oral Liquid Dosage Excipients: Revenue Forecast by Type, Global, 2020–2030~ Oral Liquid Dosage Excipients: Revenue Forecast by Region, Global, 2020–2030~ Latest Oral Liquid Drugs FDA Approvals for Children, United States, 2023~ Parenteral Excipients: Growth Metrics, Global, 2022~ Parenteral Excipients: Revenue Forecast, Global, 2020‒2030~ Parenteral Excipients: Revenue Forecast by Type, Global, 2020‒2030~ Parenteral Excipients: Revenue Forecast by Region, Global, 2020‒2030~ Latest Parenteral Drug FDA Approvals for 2023, United States~ |
| Podcast | No |
| WIP Number | PEF5-01-00-00-00 |
Global Liquid Dosage Excipients Growth Opportunities
Global Liquid Dosage Excipients Growth Opportunities
Demand for Patient-centric Parenteral Formulation Accelerates Growth Potential
RELEASE DATE
12-Sep-2023
12-Sep-2023
REGION
Global
Global
Deliverable Type
Market Research
Market Research
Research Code: PEF5-01-00-00-00
SKU: CM_2023_135
$4,950.00
In stock
SKU
CM_2023_135